(Q40560864)

21 September 2017

1 reference

title

The basis for current treatment recommendations for malignant gliomas (English)

1 reference

21 September 2017

H A Fine

1

1 reference

PubMed ID

7807189

21 September 2017

language of work or name

1 reference

1 January 1994

1 reference

Journal of Neuro-Oncology

21 September 2017

1 reference

21 September 2017

20

1 reference

21 September 2017

111-120

1 reference

21 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01052722

21 September 2017

0 references

cites work

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01052722

Treatment of astrocytoma with a 5-day cisplatin infusion

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01052722

Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group.

21 January 2018

1 reference

12 December 2020

A comparison of radiotherapy alone with radiotherapy and CCNU in cerebral glioma

1 reference

12 December 2020

Radiosurgery as part of the initial management of patients with malignant gliomas

1 reference

12 December 2020

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

12 December 2020

Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma

1 reference

12 December 2020

BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report

1 reference

12 December 2020

Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma

1 reference

12 December 2020

Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma

1 reference

12 December 2020

The role of chemotherapy in the treatment of gliomas in adults

1 reference

12 December 2020

Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group study

1 reference

12 December 2020

The accuracy of volumetric measurement of high-grade gliomas.

1 reference

12 December 2020

Epidemiology of brain tumors: the national survey of intracranial neoplasms

1 reference

12 December 2020

Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.

1 reference

12 December 2020

Survival and prognosis of patients with astrocytoma with atypical or anaplastic features.

1 reference

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

Evaluation of prognostic factors in chemotherapy of recurrent brain tumors.

1 reference

12 December 2020

Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme

1 reference

12 December 2020

Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment

1 reference

12 December 2020

Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial

1 reference

12 December 2020

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

1 reference

12 December 2020

Effect of human leukocyte interferon on malignant brain tumors.

1 reference

12 December 2020

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Influence of measurement error on assessment of response to anticancer chemotherapy: proposal for new criteria of tumor response

1 reference

12 December 2020

Assumptions in the radiotherapy of glioblastoma

1 reference

12 December 2020

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

12 December 2020

Successful chemotherapy for recurrent malignant oligodendroglioma.

1 reference

12 December 2020

Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma

1 reference

12 December 2020

Classification and incidence of neoplasms of the central nervous system

1 reference

12 December 2020

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party

1 reference

12 December 2020

High dose radiation therapy in the treatment of malignant gliomas: Final Report

1 reference

12 December 2020

Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas

1 reference

12 December 2020

Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors

1 reference

12 December 2020

Cancer statistics, 1989.

1 reference

12 December 2020

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

1 reference

12 December 2020

Patient age, histologic features, and length of survival in patients with glioblastoma multiforme.

1 reference

12 December 2020

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.

1 reference

12 December 2020

Multiple-fraction-per-day external beam radiotherapy for adults with supratentorial malignant gliomas

1 reference

12 December 2020

Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.

1 reference

12 December 2020

Northern California Oncology Group protocol 6G91: response to treatment with radiation therapy and seven-drug chemotherapy in patients with glioblastoma multiforme

1 reference

12 December 2020

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Stud

1 reference

12 December 2020

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

1 reference

12 December 2020

Radiation therapy for neoplasms of the brain.

1 reference

12 December 2020

Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications

1 reference

12 December 2020

Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas

1 reference

12 December 2020

Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine

1 reference

12 December 2020

Prognostic factors for high-grade malignant glioma: development of a prognostic index. A Report of the Medical Research Council Brain Tumour Working Party

1 reference

12 December 2020

Successful chemotherapy for newly diagnosed aggressive oligodendroglioma.

1 reference

12 December 2020

The chemotherapy of brain tumors. Clinical experience with carmustine (BCNU) and vincristine

1 reference

12 December 2020

The concept of an overview of cancer clinical trials with special emphasis on early breast cancer.

1 reference

12 December 2020

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.

1 reference

12 December 2020

Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: the UCSF experience

1 reference

12 December 2020

1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors

1 reference

12 December 2020

High activity iodine-125 interstitial implant for gliomas

1 reference

12 December 2020

Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance

1 reference

12 December 2020

Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma.

1 reference

12 December 2020

Radiotherapy for high grade gliomas

1 reference

12 December 2020

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01052722

1 reference

PubMed ID

7807189

Dimensions Publication ID

21 September 2017

0 references

1 reference

PubMed ID

7807189